Evidence map›Paper›PMID 33897902›Full record

ReviewTheranostics2021

Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon.

Yoshitaka Toyama, Rudolf A Werner, Camilo A Ruiz-Bedoya, Alvaro A Ordonez, Kei Takase, Constantin Lapa, Sanjay K Jain, Martin G Pomper, Steven P Rowe, Takahiro Higuchi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Letter to the editor.European journal of nuclear medicine and molecular imaging · 2022
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Yoshitaka ToyamaDepartment of Nuclear Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.
Camilo A Ruiz-BedoyaCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Alvaro A OrdonezCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Kei TakaseDepartment of Diagnostic Radiology, Tohoku University, Sendai, Japan.
Constantin LapaNuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
Sanjay K JainCenter for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Martin G PomperDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Steven P RoweDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Takahiro HiguchiDepartment of Nuclear Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.
Johns Hopkins University · USJohns Hopkins Medicine · USUniversitätsklinikum Würzburg · DESidney Kimmel Comprehensive Cancer Center · USTohoku University · JPUniversity of Augsburg · DE

Funding

Development of 11C-PABA as a bacteria-specific imaging agent for spinal infectionsR01EB025985 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, SANJAY, WILSON, DAVID M · 2018 to 2021
$2.7M
NIBIB NIH HHS R01 EB025985
6 · The paper itself

Abstract

In recent years, a paradigm shift from single-photon-emitting radionuclide radiotracers toward positron-emission tomography (PET) radiotracers has occurred in nuclear oncology. Although PET-based molecular imaging of the kidneys is still in its infancy, such a trend has emerged in the field of functional renal radionuclide imaging. Potentially allowing for precise and thorough evaluation of renal radiotracer urodynamics, PET radionuclide imaging has numerous advantages including precise anatomical co-registration with CT images and dynamic three-dimensional imaging capability. In addition, relative to scintigraphic approaches, PET can allow for significantly reduced scan time enabling high-throughput in a busy PET practice and further reduces radiation exposure, which may have a clinical impact in pediatric populations. In recent years, multiple renal PET radiotracers labeled with

Indexed as

AnimalsHumansKidneyMolecular ImagingPositron-Emission TomographyPrecision MedicineRadioisotopesRadionuclide ImagingRadiopharmaceuticalsUrologyRadioisotopesRadiopharmaceuticalsGlomerular filtration ratekidneymolecular imagingnephrologypositron emission tomographyrenalrenal functiontheranosticsurology

Identifiers

PMID33897902
PMCPMC8058716
OpenAlexW3155333981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.